Digital Platform Validated for Colorectal Cancer Risk Stratification and Personalized Screening Recommendations Skip to content The CRC Digest Digital Platform Validated for Colorectal Cancer Risk Stratification and Personalized Screening Recommendations Validation study of ChequeáTuColon, a digital tool designed to stratify colorectal cancer risk, detect alarm symptoms, and provide personalized guideline-based screening recommendations, shows accuracy when compared to expert gastroenterologist assessments. (Digestive Diseases
Scoping Review Identifies Barriers to Diagnostic Colonoscopy After Positive Stool-Based Screening Skip to content The CRC Digest ▪ SCREENING Scoping Review Identifies Barriers to Diagnostic Colonoscopy After Positive Stool-Based Screening Systematic review synthesizes barriers and facilitators to completing diagnostic colonoscopy after a positive non-invasive stool-based screening test (FIT, gFOBT, or multitarget stool DNA), emphasizing that timely follow-up colonoscopy is essential for reducing
MD Anderson explains DNA mismatch repair status for patients Skip to content The CRC Digest MD Anderson explains DNA mismatch repair status for patients An educational resource from MD Anderson helps patients understand mismatch repair deficiency and proficiency, key biomarkers that guide immunotherapy decisions. (UT MD Anderson Cancer Center) This content is informational only and does not constitute medical
CONFIRM trial examines race, ethnicity, and screening test use among Veterans Skip to content The CRC Digest ▪ SCREENING CONFIRM trial examines race, ethnicity, and screening test use among Veterans A study of 50,125 US Veteran participants in a randomized trial comparing colonoscopy to annual fecal immunochemical testing examined how race, ethnicity, and access to care factors relate to screening test